Circle Pharma Receives FDA Orphan Drug Designation for CID-078 for the Treatment of Small Cell Lung Cancer - Business Wire

Circle Pharma Receives FDA Orphan Drug Designation for CID-078 for the Treatment of Small Cell Lung Cancer  Business Wire ...

Circle,Pharma,Receives,FDA,Orphan,Drug,Designation,for,CID-078,for